Celldex Therapeutics, Inc.
CLDX
$18.30
$0.502.81%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.06% | -5.77% | -2.61% | 94.49% | 79.99% |
| Total Receivables | -17.84% | -44.46% | -42.57% | 1.64% | 942.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -3.70% | 170.69% | -7.76% | 61.09% | -47.09% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -4.07% | -4.08% | -2.80% | 93.50% | 75.53% |
|
|
|||||
| Total Current Assets | -4.07% | -4.08% | -2.80% | 93.50% | 75.53% |
| Net Property, Plant & Equipment | 11.41% | 17.20% | 1.41% | -6.19% | -5.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 9,009.35% | 0.00% | 0.00% | 0.00% |
| Total Assets | -3.75% | -2.65% | -2.68% | 86.60% | 66.14% |
|
|
|||||
| Total Accounts Payable | 193.09% | -70.70% | 17.56% | -7.44% | -2.57% |
| Total Accrued Expenses | 19.99% | 51.68% | 6.03% | -20.40% | 19.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.29% | -13.22% | -3.35% | 1.86% | 4.33% |
| Total Finance Division Other Current Liabilities | -32.52% | -61.99% | -5.26% | -2.78% | -5.77% |
| Total Other Current Liabilities | -32.52% | -61.99% | -5.26% | -2.78% | -5.77% |
| Total Current Liabilities | 23.08% | 16.04% | 5.20% | -15.53% | 11.82% |
|
|
|||||
| Total Current Liabilities | 23.08% | 16.04% | 5.20% | -15.53% | 11.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 38.23% | 114.57% | 69.36% | -49.35% | -28.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | -21.12% | 0.00% |
| Total Liabilities | 21.63% | 16.75% | 5.60% | -17.07% | 8.70% |
|
|
|||||
| Common Stock & APIC | 0.44% | 0.48% | 0.50% | 24.31% | 14.05% |
| Retained Earnings | -3.12% | -2.87% | -2.51% | -2.35% | -3.20% |
| Treasury Stock & Other | -37.33% | 197.08% | -20.68% | -32.16% | 54.94% |
| Total Common Equity | -4.95% | -3.41% | -2.98% | 95.40% | 73.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.95% | -3.41% | -2.98% | 95.40% | 73.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.95% | -3.41% | -2.98% | 95.40% | 73.95% |
|
|
|||||